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Summary 
B  cells  are  an abundant  population  of lymphocytes that  can  efficiently capture,  process,  and 
present antigen for recognition by activated or memory T  cells.  Controversial experiments and 
arguments  exist,  however,  as to whether B  cells are or should be involved in the priming of 
virgin T  cells in vivo. Using B  cell-deficient mice, we have studied the role of B  cells as anti- 
gen-presenting cells in a wide variety of tests, including assays of T  cell proliferation and cyto- 
kine production in responses to protein antigens, T  cell killing to minor and major histocom- 
patibility  antigens,  skin  graft rejection,  and  the  in vitro  and  in vivo responses  to shistosome 
eggs. We found that B  cells are not critical for either CD4 or CD8 T  cell priming in any of 
these systems. This finding lends support to the notion that the priming of T  cells is reserved 
for specialized cells such as dendritic cells and that antigen presentation by B cells serves distinct 
immunological functions. 
O 
ver the years and in spite of a myriad of studies,  the 
issue  of whether B  cells  play a  role  in the  initiation 
and/or  maintenance  of T  cell  immune  responses  has  re- 
mained unresolved. There are both theoretical and experi- 
mental reasons for the persistence of this controversy. The- 
oretically,  the  concern revolves around the  definition of a 
"professional" APC,  a  term first  coined to distinguish  be- 
tween those APC that can initiate the activation of a virgin 
T  cell and those that are only able to restimulate previously 
primed cells  (1).  There are two reasons, both having to do 
with T  cell tolerance, why B  cells, despite their abundance 
and ability to handle antigen, should not act as professional 
APC. The first is that they present their own idiotypes (2). 
As N. K. Jerne pointed out, T  cells can neither be tolerant 
of each idiotype, because there would be no cells left to see 
other antigens  (3),  nor can they be responsive to every id- 
iotype, lest such introspection paralyze the immune system. 
Second,  because  B  cells  tend  to  hypermutate  during  im- 
mune responses,  their superbly efficient ability to concen- 
trate and present antigens is a recipe for disaster.  Though T 
cells  are  generally  tolerant  of self antigens,  that  tolerance 
has an affinity cutoff set by the normal concentration with 
which  the  self  proteins  are  presented  by  normal  APC. 
However, newly mutated autoreactive B  cells can concen- 
trate  self proteins  to  far  greater  densities  than  those  to 
which  the  T  cells  are  tolerant.  Both  types  of theoretical 
problems are dealt with if T  cells cannot be activated by B 
cells until they have first interacted with a professional APC. 
When B  cells were  tested for their  ability to activate T 
cells,  the results were inconsistent.  In some studies,  B  cells 
appeared to be crucial for T  cell priming in vivo (4-10)  or 
were able to stimulate  T  cells in vitro  (11-23),  whereas in 
others they were not able to activate T  cells  (1,  24-30)  or 
were tolerogenic  (26,  29-32).  Since each of these  experi- 
mental  systems  either  involved  manipulations  of the  re- 
sponding T  cells or of the presenting cells or required spe- 
cially targeted antigens,  we reexamined the question using 
the  p~MT mice,  which are genetically B  cell deficient.  To 
determine the impact of the B  cell deficiency on in vivo T 
cell priming, we assessed T  cell responses in the p~MT mice 
with  the  soluble  protein  KLH,  the  eggs  from Schistosoma 
mansoni,  major histocompatibility  antigens,  and  the  minor 
H  transplantation  antigens,  H-Y  and  BALB.B  minors. 
Whether tested in vitro or in vivo, by proliferation,  cyto- 
kine  production,  CTL activity,  graft rejection,  granuloma 
formation, or eosinophilia, we found that the absence of B 
cells had little impact on T  cell responsiveness. 
Materials  and Methods 
Mice.  C57B1/6 mice (B6) (6-8 wk old) were purchased from 
Charles  RiverLaboratories  (Wilmington,  MA).  p~MT mice  (33) 
were bred at the National Institute of Allergy and Infectious Dis- 
eases, which is an accredited American Association  for Accredita- 
tion laboratory animal  care facility. When we received the mice, 
they had been partially backcrossed  from the original  129  ￿  B6 
strain to B6 and expressed a mixture of genes from the two strains. 
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the mice to the B6 strain for seven generations.  We then inter- 
crossed them to generate homozygous B cell-deficient animals. 
Antibodies.  mAbs were  either purified from ascites or were 
purchased.  The following m_Abs were  used  in this  study:  anti- 
CD4  (GK1.5  [34] and  YTA3.1.2  [35]), anti-CD8  (53-6.72; 
Pharmingen, San Diego, CA)  (36), anti-Thyl.2 (Jlj.10, Ameri- 
can  Type  Culture  Collection  [ATCC],  R.ockville,  MD)  (37), 
anti-IE (14.4.4s; ATCC) (38), antimacrophage (anti-Mac-I, M1/ 
70;  Boehringer Mannheim Corp.,  Indianapolis,  IN)  (39), anti- 
dendritic cell  (33D1,  ATCC)  (40), anti-IA (M5/114.15.2  [41] 
and AF6-120.1  [42]; Pharmingen), anti-B cell (anti-B220,  anti- 
CD45P,; Pharmingen) (43), and anti-IL-4 (11B  11; ATCC) (44). 
For FACS  |  analysis, the following mAbs were used: anti-CD4- 
PE  (RM4-4;  Pharmingen),  anti-CD8o~-Red613  (53-6.7;  Life 
Technologies, Inc., Grand Island, NY),  anti-CD45R/B220-PE 
(RA3-6B2; Pharmingen), and anti-FcyR (2.4G2; ATCC) (45). 
Cytofluorimetric Analysis.  Determination of CD4,  CD8,  and 
B220 positive  cells in the spleen was done by staining with anti- 
CD4-PE  and  anti-CD8cl-Red613  or  anti-CD45P~/B220-PE 
mAbs followed by analysis with a FACScan  ~ (Becton Dickinson 
& Co., San Jose,  CA). The anti-FcyR mAb 2.4G2 was used to 
block nonspecific staining. 
Proliferation Assays.  Five animals per group were immunized 
subcutaneously at the tail base with 50 p~g KLH in CFA. Draining 
inguinal and paraaortic lymph nodes were used 10 d later. CD4 T 
responder cells from B6 and p,MT mice were purified by negative 
selection with anti-CD8, antimacrophage,  anti-dendritic cell, and 
two anti-la mAbs with or without anti-B220 followed by beads 
coated with goat anti-mouse IgG and IgM and goat anti-rat IgG 
(Collaborative  Biomedical Products,  Bedford,  MA)  and passed 
over a magnet. APC were naive splenocytes from B6 mice treated 
with anti-CD4 (GK1.5), anti-CD8, anti-Thyl.2, and rabbit com- 
plement (Lo-tox;  Cedarlane  Laboratories Ltd.,  Hornby, Ontario, 
Canada). 2 ￿  10  s purified CD4 T cells were incubated with 2 ￿ 
10  s irradiated (3,000 rad) APC in a total of 100 t*1 of IMDM sup- 
plemented with 10% FCS, 50 U/ml penicillin, 50 txg/ml strepto- 
mycin sulfate,  50  p,g/ml gentamycin sulfate,  4  mM glutamine, 
and 50 btM 2-ME, plated in triplicate in 96-flat-bottom well mi- 
crotiter plates (Costar Corp., Cambridge, MA) in the presence of 
medium alone or graded doses of KLH for 96 h.  [3H]Thymidine 
was added during the last 18-24 h as a measure  of proliferation. 
Primary alloresponses were tested  by adding 2  ￿  10  s irradiated 
stimulator cells per well to  titrated  doses of responder CD4 T 
splenocytes in 96-flat-bottom well microtiter plates in 100 p,1 of 
medium as mentioned above.  The cells were cultured for 72 h, 
and [3H]thymidine was added 18 h before harvesting. Proliferative 
responses to schistosome egg antigens were tested 14 d after intra- 
venous injection of 5,000  S.  mansoni eggs (46, 47). 4  ￿  105 cells 
from mediastinal lymph nodes, pooled from four mice, were cul- 
tured  with  graded  concentrations of egg  antigens  for  64  h  in 
RPMI 1640, 10% FCS,  100 U/ml penicillin, 100 p~g/ml strepto- 
mycin,  10  mM  Hepes,  1  mM  sodium pyruvate,  nonessential 
amino acids, and 50 p~M 2-ME.  [3H]Thymidine was added for 
the last 18 h.  All proliferation data are  presented as averages of 
triplicates, and SE were <20% unless otherwise  indicated. 
Cytokine Assays.  At 72  h,  supematants were  removed from 
wells with 50 ~g/ml KLH or with medium alone (from prolifer- 
ation assay above) and tested for IL-2, IL-4, and IFN-~r (48). Su- 
pernatants from mediastinal  lymph node cell cultures  (as above) 
with 20  Ixg/ml soluble  egg antigens were harvested  at  24  h  to 
measure  IL-2 secretion and at 72 h to analyze IL-4 and IFN-~. 
IL-2 was measured by proliferation of CTLL-2 cells in the pres- 
ence of saturating  doses of neutralizing anti-IL-4 (11Bll) n~b. 
IL-4 was determined by proliferation of CT4S cells. IFN-',/ was 
measured  by a specific sandwich ELISA (48). All cytokine levels 
were calculated using standard curves with known amounts of re- 
combinant cytokines. 
Cytotoxicity  Tests.  B6  and IxMT  females received no injec- 
tion, 2 ￿  106 B6 male, or 2 ￿  106 IzMT male spleen cells intra- 
peritoneally. 20  d  later,  recipient spleen  cells from each  mouse 
were stimulated in vitro with B6  male  or CBA/J female spleen 
cells and tested 5 d later for killing activity by the JAM Test (49). 
Briefly,  4  ￿  106  responder spleen  cells were  cultured for  5  d 
against 2 ￿  106 irradiated (1,500 rad) stimulator spleen cells in 2 ml 
of IMDM, containing additives as above for KLH proliferation. 
They were then harvested and tested for cytotoxic activity against 
[3H]thymidine-labeled  B6 male, B6 female,  and CBA/J female 
Con A-activated blasts. The response to CBA/J cells, bearing the 
H-2  k alloantigen and the Mls  a superantigen, was used as a general 
control of responsiveness.  To study priming to H-Y in the ab- 
sence of CD4 cells, B6 and p~MT females were either untreated 
or were injected with 0.5 mg of GK1.5 and 0.1 mg of YTA3.1.2 
intraperitoneally, two synergistic anti-CD4 mAbs (50), daily for 5 d, 
and were then injected intraperitoneally  with 2 ￿  106 ~MT male 
spleen cells. 2 wk later, responder spleen cells in separate cultures 
were stimulated in vitro with B6 male and CBA/J female spleen 
cells, and they were tested  5 d later for killing activity.  Optimal 
concentrations of conditioned supernatant (Rat T-Stim without 
Con A; Collaborative Biomedical Products)  were added to all of 
the anti-H-Y cultures  so that the  conditions in wells with and 
without CD4 T cells were both supportive of CTL development. 
Staining and FACS  |  analysis of spleen cells on the day of culture 
revealed  that there were  <{).6% CD4  T  cells remaining in the 
spleens  of the  anti-CD4 mAb-treated mice.  The  staining was 
performed  using  the  anti-CD4  mAb  RM4-4,  which  is  not 
blocked by  either  GK1.5  or  YTA3.1.2  at  the  concentrations 
used. 
Tail-to-tail  Skin Grafts.  b~MT  and B6 mice were grafted with 
autologous and BALB.B  tail skin by Bailey's  method (51) with 
the modification that each graft was dabbed with a drop of super 
glue before casting. The grafts were examined daily and consid- 
ered rejected when they fell off. 
In Vivo Granuloma Formation to Schistosome Eggs.  B6 and txMT 
mice were primed with 5,000  S.  mansoni  eggs  intraperitoneally, 
challenged with 5,000 eggs intravenously  3 wk later, and killed af- 
ter 6 d. The left lung was inflated with Bouin-Hollande fixative 
and processed  to  prepare  paraffin  sections,  which were  stained 
with Litt's modification of the Dominici stain (52). The size and 
cell composition of the pulmonary granulomas were determined 
in histological  sections.  The diameters  of "-'30 granulomas  con- 
taining a single egg were measured  with an ocular micrometer, 
and volumes were calculated assuming a spherical shape. Numbers 
ofeosinophils per granuloma were evaluated in the same sections. 
Results and Discussion 
The btMT mice were created by a gene-targeted knock- 
out of the  transmembrane portion of the  IgM  molecule, 
leading to a failure of B  cell precursors to progress beyond 
the  early pre-B stage  (33).  Analysis of the  surface pheno- 
type ofsplenocytes (Fig. 1) showed that homozygous ~tMT 
mice do not have mature B220 + cells, although they have a 
few  B220  l~ immature pre-B  cells.  Our  IzMT  mice  have 
small spleens ('~30 ￿  106 cells) compared with B6 controls 
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Figure  1. Two-color cytofluorimetric analy- 
sis of  splenic CD4, CD8, and B220 expression 
in B6 and IJ.MT mice. The upper panels rep- 
resent CD4  versus CD8  cytograms, and  the 
lower panels are histograms of B220 staining. 
More than 30 mice were analyzed per group, 
and  two  representative  profiles  are  shown 
from each group. 
('~100  ￿  106),  but  the  total  number  of CD4  and  CD8  T 
cells per  spleen  is  normal  (therefore,  the  proportions  of T 
cells  are  increased).  The  original  description  of the  ~MT 
mice showed  that the frequency  ofT  cells was normal, but, 
because the total numbers  of spleen cells were  not reported, 
it is unclear whether  the numbers  ofT  cells were  also nor- 
mal.  The  differences  in  staining  patterns  in  these  two  re- 
ports might  easily be due to such differences as mouse  strain 
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Figure  2.  Responses of CD4 T  cells in p.MT and 
B6 mice to KLH, S. mansoni egg antigens, and alloge- 
neic cells.  (/1) CD4 T  cells from B6 and p~MT mice 
were tested for proliferation to graded doses of KLH. 
PPD responses were the same for both groups. B was 
performed as  in A,  with  the  addition  of anti-B220 
mAb during the purification. These are representative 
data of seven experiments with a total of 71 mice. (C) 
Graded numbers of ~MT and B6 CD4 splenic T  cells 
were  incubated with irradiated BALB/c  splenocytes 
for  72  h  and  tested  for  proliferation.  Neither  re- 
sponded  to  syngeneic  stimulators.  (D)  Proliferation 
was tested to graded doses of schistosome egg antigens. 
(E)  At 72  h,  supernatants were removed from wells 
with 50  p~g/ml  KLH or with medium alone as in B 
and tested for IL-2, IL-4, and IFN-~/.  No  cytokines 
were detected in the absence of KLH.  (F)  Supema- 
tants from mediastinal lymph node  cultures  as in D 
with 20 ~g/ml soluble egg antigens were harvested at 
24 h to measure IL-2, and at 72 h to analyze IL-4 and 
IFN-'y. In A-D, each demarcation of the x-axis repre- 
sents a point in the titration of antigen or cells. 
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intrinsic deficiency in T  cell numbers in our ~,MT mice. 
To evaluate T  cell responses to a  common protein anti- 
gen, we primed p,  MT and control B6 mice with KLH and 
measured the proliferative response of CD4 T  cells isolated 
from  the  draining lymph  nodes  10  d  after immunization. 
Fig. 2  A  shows  that,  in our first experiment,  T  cells from 
the  ~MT  mice  appeared to  proliferate less well than  the 
control B6 T  cells. However, a closer look showed that the 
background  responses  without  antigen  also  differed  be- 
tween the two T  cell populations. This difference in back- 
ground response led us to  consider the possibility that the 
elevated proliferation in the B6 T  cell preparation rmght be 
due  to  contaminating  B  cells  that  were  absent  from  the 
b~MT cell population. The elevated backgrounds and over- 
all heightened response could have been due to the follow- 
ing:  (a)  antigen  carried over by B  cells;  (b)  more  efficient 
presentation of the titrated antigen by the carried-over an- 
tigen-specific B  ceils (17, 53, 54); and/or (c) proliferation in 
the cultures of both T  and B  cells (53, 55). To compare the 
responses of normal and ~MT  T  cells without the obscur- 
ing  effects  of contaminating  B  ceils,  we  retested  T  cells 
from  the two  types of mice after rigorously removing any 
potentially remaining B  cells. These cleaner T  cell popula- 
tions generated equivalent responses, both to the KLH pro- 
tein to which they had been primed (Fig. 2/3) and to allo- 
geneic spleen cells in primary mixed lymphocyte reactions 
(Fig. 2  C). The levels ofcytokines produced after immuni- 
zation with KLH (Fig. 2 E) were also equivalent for both T 
cell populations. Thus, when we tested purified T  cells, we 
found that the in vivo priming events necessary for specific 
in  vitro  responses  did  not  seem  to  be  influenced  by  the 
presence or absence of B  cells. 
Although B  cells did not appear to be necessary for CD4 
T  cell  activation,  we  considered  the  possibility that  they 
might influence the nature of the response. Therefore,  we 
also analyzed a  system in which  Th2  responses dominate, 
namely,  the reaction to eggs of S.  mansoni.  This system is 
characterized by a  transient  Th0  response  that  matures  to 
Th2  (56-58).  Fig. 2  D  shows  the in vitro proliferation of 
IxMT and B6 lymph node cells to egg antigens 2 wk after 
primary  immunization  with  eggs  of  S.  rnansoni. Once 
again,  CD4  T  cells  from  ~MT  mice  were  able  to  be 
primed in vivo. In Fig. 2  F, we see that the lack of B  cells 
also had little influence on the pattern of cytokine produc- 
tion by the two types of mice. The overall synthesis of cy- 
tokines was higher in the IxMT mice, an increase that cor- 
related with the increase in proliferation seen in Fig. 2  D. 
Thus, in the response both to KLH and to S.  mansoni eggs, 
the pattern of cytokines depended on the antigen and not 
on the presence or absence of B  cells during priming. 
To test the role orb  cells in the induction ofcytotoxic T 
cell  responses,  we  evaluated  the  CD4  helper-dependent 
CTL response to the male antigen H-Y (59-61). We chose 
this system because we reasoned that it might be more eas- 
ily influenced by the presence of antigen-presenting B  cells 
than  a  helper-independent  CTL  response.  To  assess  the 
role of host  (female) B  cells as well as the donor  (male) B 
cells, we immunized B6 and/~MT  females with either B6 
or I~MT male spleen cells. Fig. 3 A  shows that the CTL re- 
sponses of the two types of females were indistinguishable, 
and that both B  cell-deficient and normal male spleen cells 
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Figure  3.  Cytotoxic  T  cell re- 
sponses to the male antigen H-Y in 
p.MT and B6 mice in the presence 
or absence  of CD4 cells.  The panels 
represent the  titrated responses of 
spleen cells from individual mice 
tested against B6 male, B6 female, 
and CBA/J female targets. (,4) B6 
and IxMT females received no in- 
jection, 2 X  10  e' B6 male or 2 ￿ 
I0  a btMT male spleen cells intra- 
peritoneally,  as  indicated  above 
each colunm. 20 d later they were 
tested for killing activity against B6 
male or female or CBA/J  female 
cells. (B)  B6  and  p.MT females 
were either treated with anti-CD4 
mAbs or not,  as  indicated above 
each column, and primed with 2 ￿ 
10  (, I.tMT maie spleen cells intrap- 
eritoneany.  Uninjected  B6  and 
p~MT  females were included  as 
negative controls. They were tested 
2 wk later for killing activity. 98 
nfice  were  tested  in  six  experi- 
ments. Targets are indicated on the 
right side of the  figure. Each de- 
marcation of the x-axis represents a 
point in the titration of responder 
to target ratio. 
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sponses were  also  equivalent  for the  two  groups of mice. 
To  check that  the  anti-H-Y  CTL of IxMT mice were  as 
dependent on CD4 help as were normal CTL, we depleted 
the CD4 cells  from a set of p.MT and B6 females and then 
immunized  them  with  male  IxMT  splenocytes.  Fig.  3  B 
shows  that  CD4  depletion  abolished  the  anti-H-Y  CTL 
responses from both the B6 and the  p~MT mice,  showing 
that CD4 helpers were required in both cases.  There were 
no differences between  groups when we titrated  the  male 
cell inocula (data not shown).  Together, these data suggest 
that  antigen-presenting  B  cells  are  not  required  to  prime 
either CTL or their helpers. 
Having determined that B  cells do not have much influ- 
ence on priming for in vitro reactivity, we asked if their ab- 
sence had more of a consequence when the  effector stage 
was assayed in vivo. We looked at two types of responses, 
graft rejection and granuloma formation elicited by schisto- 
some eggs. 
The role of B  cells  in graft rejection is not clear,  despite 
several studies showing the effect of antibody and of repro- 
cessing of donor antigens by host APC (62, 63). In general, 
B cells are more likely to function as APC in graft rejection 
than as effectors. To compare B6 and IzMT mice for their 
ability  to  reject  grafts,  we  transplanted  the  two  types  of 
mice with tail skin from BALB.B mice. We chose to use a 
skin  graft  that  differed  by  minor  antigens  rather  than  an 
MHC different allograft for three reasons. First, rejection of 
minor histocompatibility grafts has been shown to depend 
on both  CTL  and  Thl  type  T  helpers  (35,  64).  Second, 
since there is no known antibody production to the minor 
antigens, we could evaluate the in vivo effect of the B  cells 
themselves  rather  than  that  of  their  secreted  products. 
Third,  it  should be possible  to  assess  subtle  differences  in 
responsiveness that might have been missed with antigeni- 
cally more  disparate  grafts  (65-67).  We  found  that  there 
was  no  delay  in  the  kinetics  with  which  ~MT  mice  re- 
jected the BALB.B grafts (Fig. 4 A). In fact, the average re- 
jection  time was slightly  (2  d)  faster.  Thus,  it appears  that 
skin graft rejection occurs equally well,  if not better,  in an 
immune system lacking B cells. 
To study an in vivo response that depends on Th2 types 
of cytokines,  we  looked at  granuloma  formation  in  mice 
primed and later challenged with  S.  mansoni eggs. Fig. 4  B 
shows that there was no difference between B6 and I.tMT 
mice in granuloma size 6  d  after secondary challenge with 
eggs. In Fig. 4  C, both types of mice also produced the typ- 
ical,  IL-5-dependent,  tissue  eosinophilia  characteristic  of 
the Th2 response elicited by schistosome eggs (68). 
Overall, when taken together with several earlier studies 
(1,  24-31,  64),  our data confirm the view that B  cells  are 
not necessary for a wide variety of in vivo and in vitro T 
cell responses  (69,  70).  What  then  of the  studies  showing 
impaired  T  cell  function  in  mice  deprived  of B  cells  by 
neonatal  treatment  with  anti-IgM  antibodies  (4-10),  and 
those  showing  that  B  cells  may  be  required  in  vivo  to 
prime  T  cells  that regulate  antibody production  (Roes, J., 
and K. Rajewsky, personal communication)? Though there 
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Figure  4.  In vivo effector responses to BALB.B skin graft and schisto- 
some egg challenge. (A) Seven p.MT and five B6 mice were grafted with 
autologous and BALB.B tail skin. Kinetics of  BALB.B rejection is shown. 
A single autologous graft fell off early, whereas all other autologous grafts 
were accepted. (B) B6 and liMT mice were primed with 5,000 S. mansoni 
eggs intraperitoneally, challenged with  5,000 eggs intravenously 3 wk 
later, and killed after 6 d. Granuloma size was assessed on histological sec- 
tions from the challenged lungs. The calculated means and the SEM for 
B6 and p.MT were 8.89 -Z-_ 0.61 and 7.5 -+ 0.73 (mm  3 X 10-3), respec- 
tively. (C) Eosinophils in the granulomas were counted. Mean percentage 
ofeosinophils in the lesions were 67.5 -- 2.16 (SEM) for B6 and 63.75 -+ 
4.1 (SEM) for txMT mice. 
is  no immediately  obvious explanation  for the  differences 
in results found in the anti-IgM-treated mice, it is possible 
that the daily (or thrice weekly) injection of large amounts 
of  hyperimrnune  anti-mouse  IgM  serum  into  neonatal 
mice might have deleterious  effects  on other APC,  either 
because  of cross-reactive  antibodies,  natural  antibodies,  or 
both.  Regarding the more recent studies with  IzMT mice 
showing  a  defect  in  transferable  T  cell  help  for antibody 
production (Roes, J.,  and K.  Rajewsky, personal commu- 
nication),  there  exists  the  possibility that T  cells  that  have 
matured in the absence of B cells may have defects in toler- 
ance that preclude effective collaboration. 
Because  B  cells  have  been  shown  to  activate  T  cell 
clones in vitro (11-23) and expand memory T  cells in vivo 
(29),  we were surprised  that their absence had so little  ef- 
fect in the IzMT mice. Although we assumed that the lack 
of B  cells  would have no impact on the  initial priming of 
virgin T  cells  (1,  70), we expected that the T  cell popula- 
tions  in  the  IxMT  mice  might  not  expand  as  much,  or 
might  perhaps  make  different  classes  of  responses  from those  made  by  normal  T  cells,  but  neither  of these  re- 
sponses were affected. We can envisage several possible ex- 
planations. The first is that the in vivo microenvironment 
may ensure  that  T-B  interactions are essentially unidirec- 
tional (activated/effector T  helping B)  and that,  therefore, 
antigen presentation by B  cells normally exists only to at- 
tract previously activated T  cells. The  second explanation 
arises from the view that B  cell presentation of antigen to T 
cells can lead to two different outcomes, depending on the 
state of the T  cell. If B  cells tolerize virgin T  cells and in- 
duce the expansion of previously primed T  cells (1, 27-31, 
70), the net result may not be measurable. Finally, ifB cells 
do  present  antigen  to  activate  memory  T  cells,  this  may 
normally occur in germinal centers over greater lengths of 
time than  those we  have  measured.  Late in  the  response, 
when  the  only  remaining  antigen  is  attached  to  and  re- 
leased by follicular dendritic cells (71),  the antigen-specific 
B  cell may be the APC best able to capture enough antigen 
to maintain the response  (16,  17,  72).  In this case, a  defi- 
ciency of B cells would have a serious impact on T  cell mem- 
ory (73). 
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